Table 1.
Demographic characteristics of the study populations (mean ± SD) n (%)
| HIV (n = 71) | HCV (n = 53) | HIV/HCV (n = 66) | |
| Age (yr) | 43.3 ± 10.3a | 49.7 ± 12.5 | 45.6 ± 12.5 |
| Male gender | 50 (70) | 36 (67.9) | 49 (74.2) |
| BMI (kg/m2) | 23.6 ± 3.4a | 26.0 ± 3.6 | 22.8 ± 3.0b |
| Risk group | |||
| Transfusion | - | 17 (32.1) | 4 (6.1)b |
| Homosexual men | 21 (29.5) | - | 1 (1.5) |
| Intravenous drug use | 4 (5.6) | 7 (13.2)c | 41 (62.1) |
| Others | - | 12 (22.6) | - |
| Unknown | 9 (12.6) | 16 (30.2) | 8 (12.1) |
| HCV genotype 3:non3 | - | 7:46d | 20:46 |
| HAART | 57 (80.2) | - | 60 (90.9) |
| Alcohol | 6 (8.4) | 4 (7.5) | 5 (7.5) |
| Diabetes + IFG | 2 (2.8) | 4 (7.5)e | 11 (16.6) |
a
P < 0.002,
b
P < 0.0001 vs hepatitis C virus (HCV);
c
P < 0.0001,
d
P < 0.03,
e
P < 0.001 vs human immunodeficiency virus (HIV)/HCV. IFG: Impaired fasting glucose; BMI: Body mass index; HAART: Highly active anti-retroviral therapy.